DEF 14A

Company

AGIOS PHARMACEUTICALS, INC.

Filed

April 24, 2017

Period of Report

June 13, 2017

Accession Number

0001193125-17-134570

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →